JENNIFER LITTLEDIKE: Open Payments
NPI 1063729481 · STANSBURY PARK, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$695 in 38 payments from 17 companies in 2025. Trend: 2023 $758 · 2024 $802 · 2025 $695
Food & beverage: $695
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 10 | $170 |
| Medtronic, Inc. | 5 | $97 |
| Supernus Pharmaceuticals, Inc. | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $49 |
| Lundbeck LLC | 2 | $36 |
| Otsuka America Pharmaceutical, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $32 |
| PFIZER INC. | 2 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Astellas Pharma US Inc | 1 | $27 |
Products named: VRAYLAR, MINIMED 780G, REXULTI, Qelbree, CAPLYTA, Symbravo, NURTEC ODT, Veozah.
Industry payments across UT — which companies pay providers there.
